MN
Murali Neelakantan
About Murali Neelakantan
Data last updated:
Murali Neelakantan has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Dynomech Design Interventions Llp and Executive Centre India Limited. Formerly with 4 companies, such as Ttk Prestige Limited and Glenmark Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2,219 Cr; the largest is Executive Centre India Limited at ₹1,346 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Executive Centre India Limited U74999MH2008FLC182125 | Director | 22 Apr 2025 | 2008 | ₹1,346 Cr (FY 2025) | Active |
 Ttk Healthcare Limited L24231TN1958PLC003647 | Director | 22 Aug 2024 | 1958 | ₹873 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ttk Prestige Limited L85110TZ1955PLC015049 | Director | 25 Mar 2015 | 1955 | ₹2,790 Cr (FY 2025) | Active |
 Glenmark Pharmaceuticals Limited L24299MH1977PLC019982 | Whole-Time Director | 11 May 2017 | 1977 | ₹17,443 Cr (FY 2026) | Active |
 Khaitan & Co Llp AAA-0866 | Partner | 01 Apr 2010 | 2010 | ₹706 Cr (FY 2025) | Active |
 Dynomech Design Interventions Llp AAG-2339 | Designated Partner | 26 Apr 2016 | 2016 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murali Neelakantan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murali Neelakantan
Murali Neelakantan has 16 years in corporate governance. Holds Designated Partner and Director roles. Currently with 2 companies, including Dynomech Design Interventions Llp and Executive Centre India Limited. Formerly with 4 companies, such as Ttk Prestige Limited and Glenmark Pharmaceuticals Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹2,219 Cr; the largest is Executive Centre India Limited at ₹1,346 Cr (FY 2025).
Murali Neelakantan is associated with 2 companies as Designated Partner and Director, including Executive Centre India Limited (₹1,346 Cr), Ttk Healthcare Limited (₹873 Cr).
Murali Neelakantan has expertise in General Business, Healthcare.
Murali Neelakantan has 16 years in corporate governance.
By reported revenue, the largest current company of Murali Neelakantan is Executive Centre India Limited, with revenue of ₹1,346 Cr (FY 2025).
The 2 current companies of Murali Neelakantan that report revenue have a combined latest revenue of ₹2,219 Cr.
Murali Neelakantan currently holds positions at 2 companies: Executive Centre India Limited (₹1,346 Cr), Ttk Healthcare Limited (₹873 Cr).